» Articles » PMID: 30534040

New Strains of Hepatitis B Virus Genotype E Circulating in Nigeria

Overview
Specialty General Medicine
Date 2018 Dec 12
PMID 30534040
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hepatitis B virus (HBV) is not uncommon among persons infected with human immunodeficiency virus (HIV). Severity of HBV infection and treatment outcome are associated with specific HBV genotypes. No study has reported the types of HBV genotypes circulating among HIV-infected subjects in Nigeria. This study was designed to determine the prevalence of HBV, as well as its genotypic distribution among HIV-infected subjects in Benin City, Nigeria.

Methods: Whole blood was collected from a total of 564 HIV-infected and 250 apparently healthy HIV-negative subjects. Serodiagnosis of HBV infection was done using an immunochromatographic kit. Detection of HBV-DNA and sequencing of amplicons were done using standard molecular techniques.

Results: HIV status was not significantly associated with HBV seroinfection (HIV vs. non-HIV: 4.6% vs. 4.0%; odds ratio = 1.168, 95% confidence interval = 0.550, 2.444, and P = 0.854). HIV-infected subjects were observed to have an insignificantly (P = 0.645) higher prevalence of true HBV infection than their non-HIV-infected counterparts (HIV positive vs. HIV negative: 23.1% vs. 10.0%). All patients with true HBV infection were found to harbor HBV genotype E, which did not cluster around other HBV genotype E.

Conclusion: This study reports novel strains of HBV genotype E circulating in Nigeria.

Citing Articles

Detection of Immune Escape and Basal Core Promoter/Precore Gene Mutations in Hepatitis B Virus Isolated from Asymptomatic Hospital Attendees in Two Southwestern States in Nigeria.

Sobajo O, Oguzie J, Adegboyega B, Eromon P, Happi C, Komolafe I Viruses. 2023; 15(11).

PMID: 38005866 PMC: 10674980. DOI: 10.3390/v15112188.


Hepatitis B virus precore/core region mutations and genotypes among hepatitis B virus chronic carriers in South-Eastern, Nigeria.

Mbamalu C, Ekejindu I, Enweani I, Kalu S, Igwe D, Akaeze G Int J Health Sci (Qassim). 2021; 15(2):26-38.

PMID: 33708042 PMC: 7934135.

References
1.
Mendes-Correa M, Barone A, Cavalheiro N, Tengan F, Guastini C . Prevalence of hepatitis B and C in the sera of patients with HIV infection in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2000; 42(2):81-5. DOI: 10.1590/s0036-46652000000200004. View

2.
Egah D, Banwat E, Audu E, Iya D, Mandong B, Anele A . Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J. 2007; 13(4):961-6. View

3.
Gilson R, Hawkins A, Beecham M, Ross E, Waite J, Briggs M . Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997; 11(5):597-606. DOI: 10.1097/00002030-199705000-00007. View

4.
Kramvis A, Restorp K, Norder H, Botha J, Magnius L, Kew M . Full genome analysis of hepatitis B virus genotype E strains from South-Western Africa and Madagascar reveals low genetic variability. J Med Virol. 2005; 77(1):47-52. DOI: 10.1002/jmv.20412. View

5.
Nikolopoulos G, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X . Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009; 48(12):1763-71. DOI: 10.1086/599110. View